Phase I study of oral irinotecan as a single-agent and given sequentially with capecitabine.

Goff LW, Benson AB, LoRusso PM, Tan AR, Berlin JD, Denis LJ, Benner RJ, Yin D, Rothenberg ML
Invest New Drugs. 2012 30 (1): 290-8

PMID: 20857171 · DOI:10.1007/s10637-010-9528-x

MeSH Terms (18)

Administration, Oral Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Camptothecin Capecitabine Deoxycytidine Drug Administration Schedule Female Fluorouracil Humans Irinotecan Male Maximum Tolerated Dose Middle Aged Neoplasms Treatment Outcome

Connections (2)

This publication is referenced by other Labnodes entities: